In a filing, Aadi Bioscience Inc revealed its CHIEF EXECUTIVE OFFICER Lennon David James unloaded Company’s shares for reported $18797.0 on Oct 03 ’24. In the deal valued at $1.94 per share,9,689 shares were sold. As a result of this transaction, Lennon David James now holds 22,869 shares worth roughly $82328.40000000001.
Then, Lennon David James bought 9,689 shares, generating $18,797 in total proceeds.
Before that, Desai Neil sold 40,000 shares. Aadi Bioscience Inc shares valued at $68,316 were divested by the EXECUTIVE CHAIRMAN at a price of $1.71 per share. As a result of the transaction, Desai Neil now holds 1,171,543 shares, worth roughly $4.22 million.
Piper Sandler downgraded its Aadi Bioscience Inc [AADI] rating to a Neutral from a an Overweight in a research note published on August 27, 2024; the price target was decreased to $1.75 from $5. A number of analysts have revised their coverage, including TD Cowen’s analysts, who decreased its forecast for the stock in late August from “a Buy” to “a Hold”. Jefferies also remained covering AADI and has decreased its forecast on August 21, 2024 with a “Hold” recommendation from previously “Buy” rating. H.C. Wainwright revised its rating on December 15, 2023. It rated AADI as “a Neutral” which previously was an “a Buy”.
Price Performance Review of AADI
On Friday, Aadi Bioscience Inc [NASDAQ:AADI] saw its stock unchanged to $3.60. Over the last five days, the stock has gained 14.65%. Aadi Bioscience Inc shares have risen nearly 14.10% since the year began. Nevertheless, the stocks have risen 103.39% over the past one year. While a 52-week high of $3.81 was reached on 01/08/25, a 52-week low of $1.21 was recorded on 01/02/25. SMA at 50 days reached $2.50, while 200 days put it at $1.96.
Levels Of Support And Resistance For AADI Stock
The 24-hour chart illustrates a support level at 3.49, which if violated will result in even more drops to 3.38. On the upside, there is a resistance level at 3.68. A further resistance level may holdings at 3.76. The Relative Strength Index (RSI) on the 14-day chart is 68.20, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.45, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 12.17%. Stochastics %K at 87.83% indicates the stock is a selling.
How much short interest is there in Aadi Bioscience Inc?
A steep rise in short interest was recorded in Aadi Bioscience Inc stocks on 2024-12-13, dropping by 24496.0 shares to a total of 0.23 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 0.26 million shares. There was a decline of -10.56%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on January 11, 2022 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $45 price target.
